Short Commentary - (2015) Volume 3, Issue 4

Surprising Results of the EMPA-REG OUTCOME Study have brought a New Insight into Use of Sodium-Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes

Yuji Aoki*
Department of Internal Medicine, National Hospital Organization Matsumoto Medical Center Matsumoto Hospital, Matsumoto, Nagano, Japan
*Corresponding Author: